PHAXIAM Therapeutics
Innovative red blood cell therapeutics
- B2B
About PHAXIAM Therapeutics
Development of red blood cell-based therapies targeting cancer cell metabolism by encapsulating drugs to treat severe cancers and orphan diseases.
Key facts
- Industry
- Biotechnology
- Company size
- 11–50 employees
- Headquarters
- Lyon, Rhône-Alpes, France
- Founded
- 2004
- Revenue
- $7.5M – $59.1MTamtam estimate
- Website
- phaxiam.com
- linkedin.com/company/phaxiam
PHAXIAM Therapeutics at a glance
PHAXIAM Therapeutics is a B2B company in the Biotechnology industry, headquartered in Lyon, Rhône-Alpes, France.
PHAXIAM Therapeutics was founded in 2004.
PHAXIAM Therapeutics has 11–50 employees.
PHAXIAM Therapeutics's revenue is $7.5M – $59.1M (Tamtam estimate).
Frequently asked questions about PHAXIAM Therapeutics
What is PHAXIAM Therapeutics's revenue?
Tamtam estimates PHAXIAM Therapeutics's annual revenue at $7.5M – $59.1M.
How many employees does PHAXIAM Therapeutics have?
PHAXIAM Therapeutics has 11–50 employees.
Where is PHAXIAM Therapeutics headquartered?
PHAXIAM Therapeutics is headquartered in Lyon, Rhône-Alpes, France.
Selling to companies like PHAXIAM Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies